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Abstract
Macrophages dictate both initiation and resolution of inflammation. During acute inflamma-
tion classically activated macrophages (M1) predominate, and during the resolution phase
alternative macrophages (M2) are dominant. The molecular mechanisms involved in mac-
rophage polarization are understudied. MicroRNAs are differentially expressed in M1 and
M2 macrophages that influence macrophage polarization. We identified a role of miR-21 in
macrophage polarization, and found that cross-talk between miR-21 and the lipid mediator
prostaglandin E2 (PGE2) is a determining factor in macrophage polarization. miR-21 inhibi-
tion impairs expression of M2 signature genes but not M1 genes. PGE2 and its downstream
effectors PKA and Epac inhibit miR-21 expression and enhance expression of M2 genes,
and this effect is more pronounced in miR-21-/- cells. Among potential targets involved in
macrophage polarization, we found that STAT3 and SOCS1 were enhanced in miR-21-/-
cells and further enhanced by PGE2. We found that STAT3 was a direct target of miR-21 in
macrophages. Silencing the STAT3 gene abolished PGE2-mediated expression of M2
genes in miR-21-/- macrophages. These data shed light on the molecular brakes involved
in homeostatic macrophage polarization and suggest new therapeutic strategies to prevent
inflammatory responses.
Introduction
Macrophages are pleiotropic cells that can function as immune effectors and regulators, tissue
remodelers, or scavengers [1]. The acute inflammatory response is characterized by the pres-
ence of M1 macrophages, and the chronic or resolution inflammatory phases are mediated by
the enrichment of M2 macrophages [2]. While microbial products such as LPS and the proin-
flammatory cytokines TNF-α and IFN-induce M1 macrophages, M2 macrophages are generat-
ed in the presence of IL-4, IL-13 or IL-10 [3]. M1 are known to enhance microbial clearance
and to enhance cell recruitment to the inflammatory focus by secreting TNF-α, IL-1β, and
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nitric oxide, and M2 macrophages are known to enhance fungal phagocytosis and to secrete
pro-resolution substances including fibronectin, IL-10, TGF-β, and metalloproteases [2].
Prostaglandin E2 (PGE2) is an endogenous lipid mediator produced in abundance at sites of
inflammation and infection, and itself modulates many aspects of macrophage function [4–6].
The immunomodulatory effects of PGE2 in macrophages largely result from its ability to in-
crease intracellular cAMP through the stimulatory G protein (Gs)-coupled E prostanoid (EP)
receptors EP2 and EP4 [7]. Increases in intracellular cAMP levels activate two downstream ef-
fector molecules, cAMP-dependent protein kinase A (PKA) and the exchange protein directly
activated by cAMP-1 (Epac-1) [7–10]. Increases in intracellular cAMP generally suppress in-
nate immune functions of macrophages, including suppressing the generation of inflammatory
mediators such as TNF-α and the phagocytosis and killing of microbes [4,7,8,11–14]. However,
the role of PGE2 in the generation of M1 or M2 macrophages is poorly understood. Depending
on the cell type investigated, the PGE2/EP2-EP4/cAMP/PKA cascade has been shown to en-
hance, inhibit, or exert no effect on iNOS expression [9], an M1 marker, and PGE2 has been
shown to enhance the production of IL-10 and IL-6 [9], which generates M2 macrophages.
The molecular mechanisms by which PGE2 enhances the generation of M2 macrophages re-
main to be determined.
MicroRNAs are small oligonucleotides (* 22 nt) that bind complementary sequences in
mRNAs, usually resulting in gene silencing via translational repression or target degradation
[15]. Recent studies have shown that microRNAs are key determinants of macrophage activa-
tion, controlling the expression of a variety of molecules involved in PRR signaling and NFκB
activation [15–23]. Different microRNAs are expressed in M1 or M2 polarized macrophages
and have been shown to control macrophage polarization [24–27, 28,29]. The role of miR-21
in macrophage polarization is unknown but numerous properties of miR21 have been de-
scribed. miR-21 expression is enhanced by inflammatory stimuli, including LPS stimulation.
miR-21 impairs MyD88-dependent NFκB activation and IL-6 expression, but enhances IL-10
expression [30]. miR-21 targets the proinflammatory molecule tumor suppressor programmed
cell death protein 4 [30]. miR-21 targets other proinflammatory cytokines, such as IL-12p35,
during allergic inflammation [31]. miR-21 -/- mice exhibit lower levels of TNF-α, MIP-2, and
NFκB p65 in a model of fatal colitis [32].
Since PGE2 exerts anti-inflammatory effects in macrophages by inhibiting TNF-α and en-
hancing IL-10 levels [14,33], and lack of miR-21 exhibits similar effects, we sought to investi-
gate possible interplay between miR-21 and PGE2 that might lead to macrophage polarization.
We found that macrophages from miR-21 deficient mice are enriched in M2 macrophages and
depleted of M1 macrophages. Furthermore, miR-21 deficiency potentiates PGE2-mediated M2
macrophages in a STAT3-dependent manner.
Results
miR-21 drives M1 and inhibits M2 peritoneal macrophage polarization
The role of miR-21 in the control of macrophage polarization remains to be determined. Ini-
tially we determined the expression profile of M1 and M2 markers by real time PCR in thiogly-
collate-elicited macrophages. Our data showed that the M1 markers Tnfa, Il12p40, Il1b, and Il6
were either not detected or were detected at lower levels than observed in WTmacrophages
(Fig. 1A). We found that all M2 markers studied (Il10, Arg1, Retnla, and Chi3l3) were en-
hanced in miR-21-/- macrophages when compared to WT macrophages (Fig. 1A). These same
genotype-specific patterns of expression were observed in resident peritoneal and alveolar mac-
rophages (data not shown). Thus, further experiments were performed only in elicited macro-
phages. We confirmed that miR-21 inhibited the expression of genes present in M2
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macrophages and enhances the expression of genes enriched in M1 macrophages by treating
WT cells with the miR-21 mimic (Fig. 1B and inset). Our findings indicate that miR-21 is a
homeostatic regulator of macrophage polarization even in the absence of conventional M1 or
M2 stimuli.
PGE2 inhibits miR-21 expression in macrophages
Previously, we have shown that PGE2 enhances Il10 and Il6 production in a PKA dependent
manner [14,34]. However, the role of PGE2 and its downstream effectors in macrophage polar-
ization is poorly understood. Furthermore, whether PGE2 controls microRNA expression re-
mains to be determined. We found that PGE2 inhibited miR-21 expression both at 4 and 24 h
of stimulation compared to untreated cells (Fig. 2A). Next, we sought to determine which
cAMP downstream effector, PKA or Epac, inhibited miR-21 expression. We stimulated macro-
phages with the PKA agonist 6-Bnz-cAMP or Epac agonist 8-pCPT-2-O-Me-cAMP for differ-
ent times and found that both effectors inhibited miR-21 expression. However, while PKA
activation was more potent in inhibiting miR-21 at earlier time points, Epac activation was
more effective in reducing miR-21 expression after 24 h of activation (Fig. 2B). These results
suggest that distinct cAMP effectors that influence different transcriptional programs differen-
tially inhibit miR-21 expression.
miR-21 is an endogenous brake in PGE2-mediated M2 polarization
To study the profile of macrophage polarization in PGE2-stimulated macrophages, WT cells
were challenged with PGE2 for 4 and 24 h, and the profiles of M1 and M2-related genes in mac-
rophages were determined by real time PCR. We found that PGE2 decreased the expression of
M1 markers Tnfa and Nos2 (Fig. 3 A and B) and enhanced the expression of M2 markers
Arg1,Mmp2, and Chi3l3. While Arg1 expression was more pronounced 4 h after PGE2 stimu-
lation, the expression ofMmp2 and Chi3l3 were higher 24 h after PGE2 stimulation (Fig. 3 C-
E). When miR-21 deficient macrophages were tested, we observed that PGE2 further enhanced
M2 markers 24h after stimulation compared to M2 marker expression in WT cells (Fig. 3 C-
E). These data suggest that PGE2 enhances M2 markers, and that miR-21 acts as an endoge-
nous brake involved in the PGE2-mediated generation of M2 cells.
Fig 1. miR-21 deficiency impairs M1 and favors M2macrophage polarization. (A) Thioglycollate-elicited
macrophages fromWT and miR-21 deficient mice were isolated, and the expression of Tnfa, Il12p40, Il1b,
Arg1, Il10, IL-6, Retnla, Chi3l3, and ActinmRNA was determined by real time PCR. (B) Elicited macrophages
were transfected with the miR-21mimic or the scrambled control (30 nM each), and the expression of
Retnla, Arg1,Tnfa, Il1b and Actinwas determined by real time PCR. Inset: miR-21 mRNA expression of
macrophages transfected as in B. Data represent mean ± SEM from 3–5 individual experiments, each
performed in triplicate. *p< 0.05 versusWT cells or mimic control.
doi:10.1371/journal.pone.0115855.g001
MicroRNA 21 Inhibits M2 Polarization
PLOS ONE | DOI:10.1371/journal.pone.0115855 February 23, 2015 3 / 13
miR-21 targets STAT3 to inhibit M2 polarization
To understand the mechanisms involved in miR-21 inhibition of macrophage polarization, we
initially determined the expression profiles of proteins and transcription factors involved in
M1 and M2 polarization. We found that 24 h after PGE2 challenge the expression of STAT3
and STAT1 but not STAT6 was enhanced in WTmacrophages (Fig. 4 A and B). We also ob-
served an increase in STAT3 expression in miR-21 -/- macrophages, which PGE2 treatment en-
hanced further (Fig. 4 A). We did not observe changes in the expression of NFκB p65, SOCS3,
MyD88, or TIRAP (Fig. 4 A). We found that PGE2 treatment enhanced SOCS-1 expression
levels in both miR-21 -/- and WT macrophages (Fig. 4 A). Enhanced STAT3 expression also
correlated with increased STAT3 phosphorylation, but not STAT1 and STAT6 activation.
To further confirm that miR-21 targeted STAT3, we determined the expression of STAT3
in WT macrophages treated with miR-21 mimic or with the miR-21 antagomir (Fig. 4C). The
miR-21 mimic inhibited STAT3 expression, and the antagomir further enhanced STAT3 ex-
pression (Fig. 4 C), indicating the miR-21 targeted STAT3 expression. We then look at the pro-
tein expression of the M2 marker SOCS1 and the M1 marker SOCS3 [35–37]. We found that
the miR-21 mimic inhibited SOCS-1 expression while the antagomir enhanced SOCS-1 expres-
sion. Neither the mimic nor antagomir affected the expression of MyD88 (Fig. 4 C). To further
confirm that miR-21 directly targeted STAT3 3’UTR sequences, we transfected RAW 264.6
cells with a plasmid expressing STAT3–3’UTR luciferase or empty vector, followed by transfec-
tion of cells with miR-21 mimic or scrambled mimic. We found that miR-21 directly inhibited
STAT3 expression, indicating that miR-21 targeted STAT3–3’UTR sequences (Fig. 4 D). The
inset shows the predicted miR-21 seed sequence in the STAT3–3’UTR (www.microRNA.org;
Fig. 4 D).
Fig 2. PGE2/PKA/Epac axis inhibits miR-21 expression in macrophages. Elicited macrophages were
treated or not with 1 μMPGE2 (A) or 500 μM of PKA-specific cAMP analog 6-Bnz-cAMP or Epac-specific
cAMP analog 8-pCPT-2-O-Me-cAMP each (B) for the indicated times, and the expression of miR-21 was
determined by real time PCR. Data represent mean ± SEM from 3–5 individual experiments, each performed
in triplicate. *p< 0.05 versus unstimulated cells; # p<0.05 versus cells stimulated with PKA.
doi:10.1371/journal.pone.0115855.g002
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Fig 3. Absence of miR-21 amplifies PGE2-mediated M2 polarization. Thioglycollate-elicited macrophages fromWT and miR-21 deficient mice were
stimulated or not with PGE2 for 4 or 24 h, and the expression of Tnfa, Nos2, Arg1, Mmp2, andChi3l3mRNAwas determined by real time PCR. Data
represent mean ± SEM from 3–5 individual experiments, each performed in triplicate. *p< 0.05 versus unstimulated cells and p<0.05 versusWT
macrophages; # p< 0.05 versusWT cells stimulated with PGE2 for 24h.
doi:10.1371/journal.pone.0115855.g003
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STAT3 mediates PGE2-induction of M2 macrophages in miR-21
deficient macrophages
Since STAT3 expression was enhanced in miR-21 -/- macrophages and PGE2 stimulation fur-
ther enhanced STAT3 in these cells, we determined whether enhanced STAT3 expression in
miR-21 -/- cells stimulated with PGE2 influenced M2 polarization. We silenced STAT3 in both
WT and miR-21 deficient cells (Fig. 5A). We then stimulated with PGE2 and determined
expression of M2-markers by real time PCR (Fig. 5B-E). When STAT3 was silenced in WT
macrophages, we did not observe changes in M2 markers (Fig. 5B-E). Furthermore, STAT3
depletion did not prevent expression of M2 genes in PGE2-stimulated WTmacrophages, in-
dicating that STAT3 does not mediate homeostatic M2 polarization (Fig. 5B-E). While Stat3
silencing did not change the expression of M2 markers in WT cells, Stat3 inhibition in
miR-21 -/- macrophages inhibited the expression of Chi3l3 and enhanced Retnla and Il6
mRNA expression. While Stat3 silencing abolished PGE2-enhanced expression of Chi3l3,
Retnla, and Il6 in miR-21 -/- cells, we did not observe an effect of Stat3 inhibition on Il10
expression. These results indicate that increased M2 polarization in PGE2-stimulated
miR-21 -/- cells is dependent on STAT3 signaling.
Fig 4. miR-21 targets STAT3 in macrophages. (A) Thioglycollate-elicited macrophages fromWT and miR-21 deficient mice were stimulated or not with
PGE2 for the indicated times, and the expression of STAT3, STAT1, SOCS1, SOCS2, SOCS3, TIRAP, NFκB p65, and beta actin was determined by
immunoblotting. (B) Elicited macrophages fromWT and miR-21 deficient mice were stimulated or not with PGE2 for 24 h, and the expression of t-STAT6,
pSTAT6 (Tyr641), pSTAT1 (Tyr701), pSTAT3 (Tyr705) and beta actin was determined by immunoblotting. (C) Elicited macrophages fromWT were
transfected with 30 nM of scrambled control, miR-21, or miR-21 antagomir for 24 h, followed by determination of STAT3, MyD88, SOCS1, and beta-actin by
immunoblotting. The numbers represent mean densitometric analysis of the bands shown from 3 independent experiments. The dashed line in the figure
indicates lanes in the membrane that contained experimental conditions that were run under the same experimental conditions but not pertinent and were
omitted. Data are mean ± SEM; *p< 0.01 versusWT scrambled control-treated cells. (D) Raw264.7 macrophages were transfected with a luciferase
construct containing the 30 UTR of STAT3 and empty vector expressing luciferase reporter plasmid followed by the microRNAmimic miR-21 (30 nM) for 24 h,
and luciferase activity was determined. Inset: The predicted miR-21 seed sequence located in the 30-UTR of STAT3. Sequence alignment of miR-21 and
STAT3 is shown, and matches are indicated by a line. Data represent mean ± SEM from at least 3 individual experiments, each performed in triplicate. *p<
0.05 versus empty vector.
doi:10.1371/journal.pone.0115855.g004
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Discussion
This study highlights a novel regulatory mechanism of homeostatic M2 macrophage polariza-
tion along the PGE2/cAMP axis mediated by miR-21 (Fig. 5F). We and others have shown that
PGE2 inhibits TNF-α production and enhances IL-10 levels in macrophages from different
anatomical sites [4,7,14,38]. miR-21 deficiency also leads to low TNF-α and enhanced IL-10
production in macrophages [30,39]. Here, we extended these findings by investigating cross-
talk between PGE2 and miR-21 in the development of macrophage anti-inflammatory effects
and the molecular programs involved. We found that: 1) miR-21 deficiency inhibits the expres-
sion of M1 and enhanced M2 markers in elicited peritoneal macrophages; 2) PGE2/PKA/Epac
inhibited miR-21 expression; 3) PGE2 enhances the expression of M2 markers, and its effects
are enhanced in miR-21 deficient cells; 4) miR-21/PGE2 targets STAT3 and SOCS1, but not
STAT1, STAT6, SOCS3, or TLR adaptors; 5) STAT3 silencing prevents PGE2-induced M2
marker expression in miR-21 deficient cells.
M1 macrophages are classically induced by IFN-γ and LPS, and M2 macrophages are in-
duced by IL4 and IL-13 [39]. Furthermore, M2 macrophages can be further classified in M2a,
M2b and M2c, depending on the stimuli. Here, we show that depletion of a single microRNA
led to inhibition of M1 and enhanced M2 markers in the absence of any stimuli, indicating that
miR-21 functions to keep macrophage polarization in check, and depletion of this microRNA
favors the expression of M2 markers. Whether miR-21 differentially regulates specific M2 pop-
ulations remains to be determined. The results showed that effects of miR-21 in the deficient
mice were not the consequence of a putative compensatory mechanism that might influence
Fig 5. PGE2 utilizes STAT3 signaling to enhance M2macrophages in miR-21 deficient macrophages.
WT and miR-21 deficient macrophages were treated with 30 nM STAT3 siRNA or siRNA control for 24 h and
stimulated or not with PGE2 for another 24 h. Expression of (A) Stat3, (B) Chi3l3, (C) Retnla, and (D) Il6, (E)
Il10mRNA were determined by real time PCR. (F) Proposedmodel of miR-21 and PGE2-mediated M2
macrophage generation. Data represent mean ± SEM from at least 3 individual experiments, each performed
in triplicate. *p< 0.05 versusWT siControl; #p<0.05 versus miR-21 -/- cells and &p<0.05 versus STAT3
siRNA control.
doi:10.1371/journal.pone.0115855.g005
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the expression of different microRNAs. That miR-21 controls LPS actions has been shown.
Sheedy et al have shown that miR-21 inhibits the production of IL-6 and enhances IL-10 levels
by controlling both NFκB p65 levels and the proinflammatory molecule tumor suppressor pro-
grammed cell death 4 (PDCD4), an inhibitor of IL-10 production [15,30]. These findings are
not in perfect agreement with ours, since we found that miR-21 -/- elicited macrophages show
enhanced IL-6 and IL-10 levels, whereas Sheedy et al. show that miR-21 mimic enhances IL-6
and decrease IL-10 levels [30]. The reason for this discrepancy is uncertain, but there are
several differences in the respective experiments. Sheedy et al studied miR-21 effects in a mac-
rophage cell line and bone marrow derived macrophages; whereas, we performed our experi-
ments in thioglycollate-elicited macrophages, which exhibit an inflammatory phenotype [30].
Also, we investigated the role of miR-21 in basal/homeostatic expression of these cytokines,
and Sheedy et al determined the production of IL-16 and IL-10 in LPS-stimulated cells [30].
Whether thioglycollate-elicited miR-21 deficient macrophages respond to LPS in the same
manner as cell lines or bone marrow macrophages remains to be determined. Our results are
in agreement with Shi et al. who showed in a model of colitis that M1-like cytokines such as
TNF-αand MIP-2 are decreased in miR-21 deficient mice [32]. Clearly, the elucidation of
such cell-specific functions of miR-21 should help in the development of effective miR-based
therapeutic strategies.
Here, we investigated the role of the cAMP inducer PGE2 in the expression of miR-21 in
macrophages. Our data show that PGE2 challenge decreased miR-21 expression, and incuba-
tion of macrophages with the downstream effectors PKA or the Epac agonist also decreased
miR-21 levels. Whether the cAMP/PKA/Epac axis influences global microRNA expression and
their effects in macrophage biology remains to be determined. These data lead us to speculate
that miR-21 acts as a brake on PGE2 effects, and PGE2-mediated miR-21 inhibition is part of
an inhibitory loop involved in macrophage M2 polarization by the PGE2/PKA/Epac axis.
The molecular mechanisms involved in miR-21 and PGE2-induced M2 macrophages were
studied. Initially, we tested whether miR-21 inhibition influenced EP 1–4 mRNA expression,
but we did not observe any differences in the expression of these receptors between WT and
miR-21 -/- cells or WT cells treated with miR-21 mimic (data not shown). We also did not ob-
serve any change in the expression of the CREB (data not shown). We next investigated which
transcription factors and effectors were involved in enhanced expression of M2 genes. While
STAT6 is activated by IL-4 and IL-13 [40], and has been suggested to be the master regulator
of M2 differentiation, STAT1 and NFκB are thought to be essential for M1 generation [40].
We did not observe a change in the expression of STAT6 and phosphorylation in miR-21-/-
macrophages, which led us to study the expression of other STAT proteins in miR-21 deficient
cells, and to ask whether PGE2 further influenced the expression of these proteins. We found
that STAT3 and STAT1 levels were enhanced in miR-21-/- macrophages, and treatment with
PGE2 further enhanced STAT3 expression and phosphorylation, but not STAT1 activation
when compared to WT cells. That miR-21 expression is controlled by STAT3 has been
shown [41–43]; however, whether miR-21 controls STAT3 levels is unknown. We found that
miR-21 -/- and miR-21 antagomir transfection enhanced STAT3 levels, and conversely,
miR-21 mimic decreased STAT3. Whether miR-21 directly targets SOCS1 and whether
STAT3 controls SOCS1 levels in a PGE2 dependent manner is under investigation.
PGE2 is known to control STAT3 activation and expression [44–47]. However, whether
PGE2 utilizes STAT3 to inhibit macrophage function is poorly understood. Here, we found
that Stat3 silencing abolished PGE2-enhanced expression of Chi3l3, Retnla, and Il6 in miR-
21 -/- cells, we did not observe an effect of Stat3 inhibition on Il10 expression. The mechanisms
involved in PGE2-induced STAT3 activation in macrophages remain to be determined. Frias
et al, have shown that PGE2 enhances STAT3 phosphorylation in a manner dependent on ERK
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1/2 activation but not on p38 MAPK activation [44,48]. Singh et al showed that PGE2 enhances
STAT3 expression [49]. Another potential mechanism by which PGE2 enhances M2 dependent
genes in a STAT3 dependent manner is through the production of Il6, which is known to in-
duce STAT3 activation [50–52] and M2 generation [53]. Pretreatment of both PGE2 stimulated
WT and miR-21 cells with anti-IL-6 did not prevent PGE2 effects on the expression of M2
genes (data not shown). Therefore, it still remains to be determined how PGE2 influences the
expression of M2 dependent genes, and how miR-21 interferes with PGE2 signaling.
Effects of microRNAs on cytokine signaling and their consequences for macrophage biology
may be a root cause of inflammation [24,54,55]. There are numerous approved pharmaceuti-
cals that target STAT3. As well, specific microRNA mimics or antagomirs are also known to
control the inflammatory response [24,54,55], and the use of such microRNAs to treat inflam-
matory diseases represents a potent therapeutic approach. In conditions were acute inflamma-
tion needs to be controlled, miR-21 antagomirs may be a good therapeutic agents that increase
the numbers of M2 macrophages and decrease the expression of master inflammatory media-
tors such as IL-1β and TNF-α. Alternatively, miR-21 mimics could block chronic inflammatory
responses by preventing M2 formation. In view of its role in inflammation, additional studies




8-week-old female WT C57BL/6 mice (The Jackson Laboratory) or miR-21 deficient mice
(miR-21 -/-) and counterpart WT [56] were maintained according to NIH guidelines for the
use of experimental animals with the approval of the Indiana University School of Medicine
Animal Care and Use Committees (Protocol Number: 10238). Surgical procedures were per-
formed under isofluorane anesthesia and all necessary steps to minimize suffering were taken.
Cell harvest and stimulation
Elicited macrophages were harvested from the peritoneal cavities of mice by lavage with PBS 4
days after the injection of 2 ml 3% thioglycollate as described previously [8]. Macrophages
were stimulated with 1 μM PGE2 [14,33] or 500 μM PKA-specific cAMP analog 6-Bnz-cAMP
(N6-benzoyladenosine-30,50-cyclic monophosphate), or Epac-specific cAMP analog 8-pCPT-2-
O-Me-cAMP (8–4-chlorophenylthio)-20-O-methyladenosine-30,50-cyclic monophosphate)
[12,14,34] for 24 h followed by RNA or protein isolation.
Immunoblotting
Western blots were performed as previously described [8,9]. Protein samples were resolved by
SDS-PAGE, transferred to a nitrocellulose membrane, and probed with commercially available
primary antibodies against STAT3, STAT1, TIRAP, MyD88, NFκB p65, SOCS-1-3 (all at
1:500; Abcam), phosphorylated STAT3 (Tyr705), STAT1 (Tyr701) and STAT6 (Tyr641) (all at
1:1000; Cell Signaling) or β-actin (1:10,000; Sigma-Aldrich). Densitometric analysis was per-
formed as described previously [8,9].
RNA analysis
Total RNA from cultured cells was isolated using the miRNeasy Mini Kit (Qiagen) according
to the manufacturer’s instructions. Quantitative RT-PCR analyses for miR-21 and RNU6 (used
as a normalization control) were performed using TaqMan miRNA assays with reagents,
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primers, and probes obtained from Qiagen. In brief, a stem loop primer was used for reverse
transcription (30 min, 16°C; 30 min, 42°C; 5 min 85°C) followed by qPCR employing TaqMan
probes and primers in a Bio-rad CFX96 Mastercycler. For assessing expression of Socs1,
Myd88, Stat3, Il10, Chi3l3, Il6, Retnla, Nos2, Tnfa, Arg1, Mmp2, and actin, cDNA was synthe-
sized using a reverse transcription system (miScript II—Qiagem). qPCR was performed on a
CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories) as described [9]. Primers
were purchased from Integrated DNA technologies. Relative expression was calculated using
the comparative threshold cycle (Ct) and expressed relative to control or WT (ΔΔCt method).
Targeted miRNA inhibition and overexpression
For inhibition of miR-21, macrophages were transfected using lipofectamine siRNA max trans-
fection reagents with appropriate target anti-miR-21 antagomir or anti-miR-negative control 1
(anti-miR-control) [57]. For overexpression, macrophages were transfected with pre-miR-21
or pre-miR-negative control 1 (pre-miR-control) [57]. Transfection reagents, antagomirs, and
control miRNAs were purchased from Invitrogen. Knockdown efficiency and overexpression
efficiency were assessed by determining mature miR-21 levels in transfected cells. Transfected
cells were treated with or without 30 nMmicroRNA mimic or antagomir for 48 h before col-
lecting supernatants or preparing cell lysates for isolation of RNA (RNeasy kit, Qiagen)
or proteins.
Luciferase assays
Plasmids containing the 30UTR of murine STAT3 were purchased from Genecopeia. The Raw
264.7 macrophage cell line was transfected with constructs in 6-well plates using lipofectamine
siRNA max (Invitrogen). Firefly luciferase reporter gene constructs (0.1 μg per well) were co-
transfected together with 30 nM of miR-21 or scrambled-miR control; cells were lysed 24 h
after transfection, and luciferase activity was measured. Each sample was assayed in triplicate
as described [57].
Statistics
Data are presented as mean ± SEM. Comparisons among groups were assessed with ANOVA
followed by Bonferroni analysis; p< 0.05 was considered significant.
Acknowledgments
This work was supported by National Institutes of Health Grants 1R21AI079349-01 (to A. D.),
HL-103777-01 and HL-124159-01 (C. H. S.) and T32AI060519 (to S.B.), Ralph W. and Grace
M. Showalter Research Trust Fund and Fundação de Amparo a Pesquisa do Estado de São
Paulo. The funders had no role in study design, data collection and analysis, decision to pub-
lish, or preparation of the manuscript.
Author Contributions
Conceived and designed the experiments: ZW SB AM SW. Performed the experiments: ZW SB
AM SWHW. Analyzed the data: ZW SB AM SWHWAD CHS. Contributed reagents/materi-
als/analysis tools: AD CHS. Wrote the paper: CHS.
MicroRNA 21 Inhibits M2 Polarization
PLOS ONE | DOI:10.1371/journal.pone.0115855 February 23, 2015 10 / 13
References
1. Galli SJ, Borregaard N, Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity:
macrophages, mast cells and neutrophils. Nat Immunol 12: 1035–1044. doi: 10.1038/ni.2109 PMID:
22012443
2. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev
Immunol 11: 723–737. doi: 10.1038/nri3073 PMID: 21997792
3. Edwards JP, Zhang X, Frauwirth KA, Mosser DM (2006) Biochemical and functional characterization of
three activated macrophage populations. J Leukoc Biol 80: 1298–1307. PMID: 16905575
4. Medeiros AI, Serezani CH, Lee SP, Peters-Golden M (2009) Efferocytosis impairs pulmonary macro-
phage and lung antibacterial function via PGE2/EP2 signaling. J Exp Med 206: 61–68. doi: 10.1084/
jem.20082058 PMID: 19124657
5. Serezani CH, Chung J, Ballinger MN, Moore BB, Aronoff DM, et al. (2007) Prostaglandin E2 sup-
presses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am J Respir Cell Mol
Biol 37: 562–570. PMID: 17585108
6. Zaslona Z, Serezani CH, Okunishi K, Aronoff DM, Peters-Golden M (2012) Prostaglandin E2 restrains
macrophagematuration via E prostanoid receptor 2/protein kinase A signaling. Blood 119: 2358–2367.
doi: 10.1182/blood-2011-08-374207 PMID: 22234697
7. Aronoff DM, Hao Y, Chung J, Coleman N, Lewis C, et al. (2008) Misoprostol impairs female reproduc-
tive tract innate immunity against Clostridium sordellii. J Immunol 180: 8222–8230. PMID: 18523288
8. Medeiros A, Peres-Buzalaf C, Fortino Verdan F, Serezani CH (2012) Prostaglandin E2 and the sup-
pression of phagocyte innate immune responses in different organs. Mediators Inflamm 2012: 327568.
PMID: 23024463
9. Kim SH, Serezani CH, Okunishi K, Zaslona Z, Aronoff DM, et al. (2011) Distinct protein kinase A an-
choring proteins direct prostaglandin E2 modulation of Toll-like receptor signaling in alveolar macro-
phages. J Biol Chem 286: 8875–8883. doi: 10.1074/jbc.M110.187815 PMID: 21247892
10. Lee SP, Serezani CH, Medeiros AI, Ballinger MN, Peters-Golden M (2009) Crosstalk between prosta-
glandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial ef-
fects on cyclic AMP. J Immunol 182: 530–537. PMID: 19109185
11. Serezani CH, Aronoff DM, Jancar S, Mancuso P, Peters-Golden M (2005) Leukotrienes enhance the
bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of
NADPH oxidase. Blood 106: 1067–1075. PMID: 15718414
12. Flamand N, Mancuso P, Serezani CH, Brock TG (2007) Leukotrienes: mediators that have been type-
cast as villains. Cell Mol Life Sci 64: 2657–2670. PMID: 17639273
13. Brock TG, Serezani CH, Carstens JK, Peters-Golden M, Aronoff DM (2008) Effects of prostaglandin E2
on the subcellular localization of Epac-1 and Rap1 proteins during Fcgamma-receptor-mediated
phagocytosis in alveolar macrophages. Exp Cell Res 314: 255–263. PMID: 18021770
14. Morato-Marques M, Campos MR, Kane S, Rangel AP, Lewis C, et al. (2011) Leukotrienes target F-
actin/cofilin-1 to enhance alveolar macrophage anti-fungal activity. J Biol Chem 286: 28902–28913.
doi: 10.1074/jbc.M111.235309 PMID: 21715328
15. O'Neill LA, Sheedy FJ, McCoy CE (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling.
Nat Rev Immunol 11: 163–175. doi: 10.1038/nri2957 PMID: 21331081
16. Xu G, Zhang Z, Xing Y, Wei J, Ge Z, et al. (2014) MicroRNA-149 negatively regulates TLR-triggered in-
flammatory response in macrophages by targeting MyD88. J Cell Biochem 115: 919–927. doi: 10.
1002/jcb.24734 PMID: 24375488
17. Banerjee S, Cui H, Xie N, Tan Z, Yang S, et al. (2013) miR-125a-5p regulates differential activation of
macrophages and inflammation. J Biol Chem 288: 35428–35436. doi: 10.1074/jbc.M112.426866
PMID: 24151079
18. Wei J, Huang X, Zhang Z, Jia W, Zhao Z, et al. (2013) MyD88 as a target of microRNA-203 in regulation
of lipopolysaccharide or Bacille Calmette-Guerin induced inflammatory response of macrophage
RAW264.7 cells. Mol Immunol 55: 303–309. doi: 10.1016/j.molimm.2013.03.004 PMID: 23522925
19. Mardente S, Mari E, Consorti F, Di Gioia C, Negri R, et al. (2012) HMGB1 induces the overexpression
of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncol Rep
28: 2285–2289. doi: 10.3892/or.2012.2058 PMID: 23023232
20. Gantier MP, Stunden HJ, McCoy CE, Behlke MA, Wang D, et al. (2012) A miR-19 regulon that controls
NF-kappaB signaling. Nucleic Acids Res 40: 8048–8058. PMID: 22684508
21. Bala S, Marcos M, Kodys K, Csak T, Catalano D, et al. (2011) Up-regulation of microRNA-155 in macro-
phages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased
MicroRNA 21 Inhibits M2 Polarization
PLOS ONE | DOI:10.1371/journal.pone.0115855 February 23, 2015 11 / 13
mRNA half-life in alcoholic liver disease. J Biol Chem 286: 1436–1444. doi: 10.1074/jbc.M110.145870
PMID: 21062749
22. Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC (2010) MicroRNA-155 silencing enhances inflammatory re-
sponse and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J
Investig Med 58: 961–967. doi: 10.231/JIM.0b013e3181ff46d7 PMID: 21030878
23. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, et al. (2009) miR-147, a microRNA that is induced upon
Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad
Sci U S A 106: 15819–15824. doi: 10.1073/pnas.0901216106 PMID: 19721002
24. AlamMM, O'Neill LA (2011) MicroRNAs and the resolution phase of inflammation in macrophages. Eur
J Immunol 41: 2482–2485. doi: 10.1002/eji.201141740 PMID: 21952801
25. Arranz A, Doxaki C, Vergadi E, Martinez de la Torre Y, Vaporidi K, et al. (2012) Akt1 and Akt2 protein ki-
nases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 109: 9517–9522.
doi: 10.1073/pnas.1119038109 PMID: 22647600
26. Banerjee S, Xie N, Cui H, Tan Z, Yang S, et al. (2013) MicroRNA let-7c Regulates Macrophage Polari-
zation. J Immunol 190: 6542–6549. doi: 10.4049/jimmunol.1202496 PMID: 23667114
27. Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME (2012) Identifying functional microRNAs in
macrophages with polarized phenotypes. J Biol Chem 287: 21816–21825. doi: 10.1074/jbc.M111.
327031 PMID: 22549785
28. El Gazzar M, Church A, Liu T, McCall CE (2011) MicroRNA-146a regulates both transcription silencing
and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J Leukoc Biol 90:
509–519. doi: 10.1189/jlb.0211074 PMID: 21562054
29. Jiang M, Xiang Y, Wang D, Gao J, Liu D, et al. (2012) Dysregulated expression of miR-146a contributes
to age-related dysfunction of macrophages. Aging Cell 11: 29–40. doi: 10.1111/j.1474-9726.2011.
00757.x PMID: 21981419
30. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. (2010) Negative regula-
tion of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNAmiR-21.
Nat Immunol 11: 141–147. doi: 10.1038/ni.1828 PMID: 19946272
31. Lu TX, Munitz A, Rothenberg ME (2009) MicroRNA-21 is up-regulated in allergic airway inflammation
and regulates IL-12p35 expression. J Immunol 182: 4994–5002. doi: 10.4049/jimmunol.0803560
PMID: 19342679
32. Shi C, Liang Y, Yang J, Xia Y, Chen H, et al. (2013) MicroRNA-21 knockout improve the survival rate in
DSS induced fatal colitis through protecting against inflammation and tissue injury. PLoS One 8:
e66814. doi: 10.1371/journal.pone.0066814 PMID: 23826144
33. Domingo-Gonzalez R, Katz S, Serezani CH, Moore TA, Levine AM, et al. (2013) Prostaglandin E2-in-
duced changes in alveolar macrophage scavenger receptor profiles differentially alter phagocytosis of
Pseudomonas aeruginosa and Staphylococcus aureus post-bone marrow transplant. J Immunol 190:
5809–5817. doi: 10.4049/jimmunol.1203274 PMID: 23630358
34. Rogers LM, Thelen T, Fordyce K, Bourdonnay E, Lewis C, et al. (2014) EP4 and EP2 receptor activa-
tion of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii.
Am J Reprod Immunol 71: 34–43. doi: 10.1111/aji.12153 PMID: 23902376
35. Spence S, Fitzsimons A, Boyd CR, Kessler J, Fitzgerald D, et al. (2013) Suppressors of cytokine signal-
ing 2 and 3 diametrically control macrophage polarization. Immunity 38: 66–78. doi: 10.1016/j.immuni.
2012.09.013 PMID: 23177319
36. Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, et al. (2012) SOCS3 deficiency promotes
M1 macrophage polarization and inflammation. J Immunol 189: 3439–3448. PMID: 22925925
37. Whyte CS, Bishop ET, Ruckerl D, Gaspar-Pereira S, Barker RN, et al. (2011) Suppressor of cytokine
signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc
Biol 90: 845–854. doi: 10.1189/jlb.1110644 PMID: 21628332
38. Weinlich R, Bortoluci KR, Chehab CF, Serezani CH, Ulbrich AG, et al. (2008) TLR4/MYD88-dependent,
LPS-induced synthesis of PGE2 by macrophages or dendritic cells prevents anti-CD3-mediated
CD95L upregulation in T cells. Cell Death Differ 15: 1901–1909. doi: 10.1038/cdd.2008.128 PMID:
18820644
39. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immu-
nol 8: 958–969. doi: 10.1038/nri2448 PMID: 19029990
40. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity
with identity. Nat Rev Immunol 11: 750–761. doi: 10.1038/nri3088 PMID: 22025054
41. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K (2010) STAT3 activation of miR-21 and miR-
181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell
39: 493–506. doi: 10.1016/j.molcel.2010.07.023 PMID: 20797623
MicroRNA 21 Inhibits M2 Polarization
PLOS ONE | DOI:10.1371/journal.pone.0115855 February 23, 2015 12 / 13
42. Yang CH, Yue J, Pfeffer SR, Handorf CR, Pfeffer LM (2011) MicroRNAmiR-21 regulates the metastatic
behavior of B16 melanoma cells. J Biol Chem 286: 39172–39178. doi: 10.1074/jbc.M111.285098
PMID: 21940630
43. Luo F, Xu Y, Ling M, Zhao Y, XuW, et al. (2013) Arsenite evokes IL-6 secretion, autocrine regulation of
STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation
of human bronchial epithelial cells. Toxicol Appl Pharmacol 273: 27–34. doi: 10.1016/j.taap.2013.08.
025 PMID: 24004609
44. Frias MA, Somers S, Gerber-Wicht C, Opie LH, Lecour S, et al. (2008) The PGE2-Stat3 interaction in
doxorubicin-induced myocardial apoptosis. Cardiovasc Res 80: 69–77. doi: 10.1093/cvr/cvn171
PMID: 18567640
45. Barclay JL, Anderson ST, Waters MJ, Curlewis JD (2007) Characterization of the SOCS3 promoter re-
sponse to prostaglandin E2 in T47D cells. Mol Endocrinol 21: 2516–2528. PMID: 17636039
46. Cheon H, Rho YH, Choi SJ, Lee YH, Song GG, et al. (2006) Prostaglandin E2 augments IL-10 signaling
and function. J Immunol 177: 1092–1100. PMID: 16818766
47. Rummel C, Sachot C, Poole S, Luheshi GN (2006) Circulating interleukin-6 induces fever through a
STAT3-linked activation of COX-2 in the brain. Am J Physiol Regul Integr Comp Physiol 291: R1316–
1326. PMID: 16809483
48. Frias MA, RebsamenMC, Gerber-Wicht C, Lang U (2007) Prostaglandin E2 activates Stat3 in neonatal
rat ventricular cardiomyocytes: A role in cardiac hypertrophy. Cardiovasc Res 73: 57–65. PMID:
17067562
49. Singh P, Hoggatt J, Hu P, Speth JM, Fukuda S, et al. (2012) Blockade of prostaglandin E2 signaling
through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hemato-
poietic progenitor cells. Blood 119: 1671–1682. doi: 10.1182/blood-2011-03-342428 PMID: 22110249
50. Lee MM, Chui RK, Tam IY, Lau AH, Wong YH (2012) CCR1-mediated STAT3 tyrosine phosphorylation
and CXCL8 expression in THP-1 macrophage-like cells involve pertussis toxin-insensitive Galpha(14/
16) signaling and IL-6 release. J Immunol 189: 5266–5276. doi: 10.4049/jimmunol.1103359 PMID:
23125416
51. Dominguez-Soto A, Sierra-Filardi E, Puig-Kroger A, Perez-Maceda B, Gomez-Aguado F, et al. (2011)
Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated
macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10. J Immu-
nol 186: 2192–2200. doi: 10.4049/jimmunol.1000475 PMID: 21239715
52. Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS (2011) Extracellular hepatitis C virus
core protein activates STAT3 in humanmonocytes/macrophages/dendritic cells via an IL-6 autocrine
pathway. J Biol Chem 286: 10847–10855. doi: 10.1074/jbc.M110.217653 PMID: 21282107
53. Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, et al. (2014) Signaling by IL-6 promotes alternative
activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immu-
nol 15: 423–430. doi: 10.1038/ni.2865 PMID: 24681566
54. Bi Y, Liu G, Yang R (2009) MicroRNAs: novel regulators during the immune response. J Cell Physiol
218: 467–472. doi: 10.1002/jcp.21639 PMID: 19034913
55. Liu G, Abraham E (2013) MicroRNAs in immune response and macrophage polarization. Arterioscler
Thromb Vasc Biol 33: 170–177. doi: 10.1161/ATVBAHA.112.300068 PMID: 23325473
56. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, et al. (2010) Modulation of K-Ras-
dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282–293. doi: 10.1016/j.ccr.2010.08.
013 PMID: 20832755
57. Wang Z, Filgueiras LR, Wang S, Serezani AP, Peters-Golden M, et al. (2014) Leukotriene B4 enhances
the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation. J
Immunol 192: 2349–2356. doi: 10.4049/jimmunol.1302982 PMID: 24477912
MicroRNA 21 Inhibits M2 Polarization
PLOS ONE | DOI:10.1371/journal.pone.0115855 February 23, 2015 13 / 13
